Abstract:AbstractGlobally there are upwards of 35 million people living with dementia and other cognitive impairments, with total annual costs of approximately US$ 1 trillion by 2025. Yet, this estimate does not consider the impact due to the lack of specialized personnel and health care infrastructure to provide timely access for dementia diagnosis, treatment, and care. These factors are complicated by the lack of valid and equitable means for detecting signs of impending cognitive impairment or dementia. Also, these same symptoms are not easily recognized by many primary care physicians who do not make referrals to specialists. These negative dynamics on access to quality brain healthcare may impact under‐represented, underserved, and vulnerable populations at disproportionately greater levels. Although more AD/ADRD interventions will be approved, this will not assure equal market access. There is an immediate need to provide accurate, affordable, appropriate, and equitable clinical care profiles. One approach is to develop digital tools to access electronic health record (EHR) data. Yet, generic EHR data on dementia status are limited to people who have received a formal diagnosis. Worse, in the community setting, most people enduring cognitive impairment or living with dementia will not receive generally a timely diagnosis to support useful clinical care decision‐making. Fortunately, several international health data reservoirs exist that integrate routine EHR data with dementia research‐driven cohort studies with affiliated biobanks, including Sheba Medical Center (SMC) with its ongoing ‐omics and neuroimaging research. As Israel has socialized medicine, and all residents have healthcare provided through the Israeli National Health Insurance law, the Sheba data offers a unique opportunity to develop valid, reliable, and transportable EHR derived assessment tools for cognitive impairment and dementia. The project in collaboration with SMC and Maccabi Healthcare Service—one of four national Israeli medical service providers—demonstrates the advanced capabilities to use electronic medical records linked with a national network of primary care physicians, and the ability to conduct deep‐source data mining in the absence of a clinical diagnosis of cognitive impairment or dementia. The project reports the performance characteristics (i.e., sensitivity and specificity) of assessment tools to detect cognitive impairment or dementia.

Evaluating Cognitive Impairment in a Large Health Care System: The Cognition in Primary Care Program

Primary care detection of cognitive impairment leveraging health and consumer technologies in underserved US communities: protocol for a pragmatic randomised controlled trial of the MyCog paradigm

EARLY DETECTION OF MILD COGNITIVE IMPAIRMENT (MCI) IN PRIMARY CARE

Non-literacy biased, culturally fair cognitive detection tool in primary care patients with cognitive concerns: a randomized controlled trial

Confidence in diagnosing and managing care for cognitive impairment in primary care: a survey comparing barriers by primary care clinician type

Using digital assessment technology to detect neuropsychological problems in primary care settings

Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care

Detecting Unrecognized Cognitive Impairment and Dementias Using Clinical Health Systems Bioinformatics and Electronic Health Records from a National Population

Design and Evaluation of a Cognitive Health Education Pilot Program According to the RE-AIM Framework

Identifying Amnestic Mild Cognitive Impairment in Primary Care

Automated Medical Records Review for Mild Cognitive Impairment and Dementia

Stakeholder-informed pragmatic trial protocol of the TabCAT-BHA for the detection of cognitive impairment in primary care

Automated detection of cognitive impairment in clinical practice

Feasibility and Acceptability of Providing Cognitive Remediation in a Large USA System of Coordinated Specialty Care for Early Psychosis

go4cognition: Evaluation of a Newly Developed Multicomponent Intervention in Mild Cognitive Impairment

Improving clinical efficiency in screening for cognitive impairment due to Alzheimer's

Implementation of Cognitive Health Services in Large Systems of Care: Highlights From Coordinated Specialty Care for First Episode Psychosis

Current Advances in Computerized Cognitive Assessment for Mild Cognitive Impairment and Dementia in Older Adults: A Systematic Review

The Computerized Cognitive Composite (C3) in A4, an Alzheimer’s Disease Secondary Prevention Trial

Dementia and Falls Management in Underserved Populations: The Cognition and Mobility Care Management Program

Real-world diagnostic, referral, and treatment patterns in early Alzheimer's disease among community-based practices in the United States